Delivery Order SPE2DB20D2104-SPE2DB24FT26Q
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Jardiance 25 mg tablets. The contract has a ceiling value of $15,658.69 and an ultimate completion date of December 29, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,360.35, is for the delivery of Jardiance 25 mg tablets. The award is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $2,387.90 and a performance period ending on July 1, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC provides a mechanism for the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $17,136.68 and runs through September 7, 2022. The contract is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which has a larger IDC with the DLA Troop Support Medical valued at up to...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Jardiance 10 mg tablets. The contract has a ceiling value of $1,753.77 and was awarded by the Defense Logistics Agency (DLA) on November 3, 2021, with a completion date of November 4, 2021. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $5,026.68 and an ultimate completion date of February 8, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 10 mg tablets. The contract has a ceiling value of $12,600.49 and a period of performance through June 6, 2024. The contract is a delivery order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency Troop Support Medical, a division of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The single-award Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical is valued at up to $999,999,999.00 and runs through December...
- This federal contract award is to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $7,716.25 and an ultimate completion date of January 4, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on January 3, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Jardiance 25 mg tablets in 90-count packages, with a ceiling value of $8,962.95 and a performance period ending on November 30, 2023. This order is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT26QDelivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has a total ceiling value of $7,953.73. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen is the prime contractor, and there are no major subcontractors mentioned. The contract has an ultimate completion date of March 27, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 3/26/24 |